Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nutritional considerations with antiobesity medications
Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury, et al.
Obesity (2024) Vol. 32, Iss. 9, pp. 1613-1631
Open Access | Times Cited: 21

Showing 21 citing articles:

Body composition changes during weight reduction with tirzepatide in the SURMOUNT‐1 study of adults with obesity or overweight
Michelle Look, Julia P. Dunn, Robert F. Kushner, et al.
Diabetes Obesity and Metabolism (2025)
Open Access | Times Cited: 2
The impact of weight loss on fat-free mass, muscle, bone and hematopoiesis health: Implications for emerging pharmacotherapies aiming at fat reduction and lean mass preservation
Konstantinos Stefanakis, Michail Kokkorakis, Christos S. Mantzoros
Metabolism (2024), pp. 156057-156057
Closed Access | Times Cited: 15
Proposed Nutrition Competencies for Medical Students and Physician Trainees
David M. Eisenberg, Alexis Cole, Edward J. Maile, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435425-e2435425
Open Access | Times Cited: 9
Use of glucagon‐like peptide‐1 receptor agonists and incretin mimetics for type 2 diabetes and obesity: A narrative review
Jason Zupec, R Munger, Alice L. Scaletta, et al.
Nutrition in Clinical Practice (2025)
Closed Access
Adipositas und Diabetes
Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, et al.
Diabetes aktuell (2025) Vol. 23, Iss. 02, pp. 59-68
Closed Access
Obesity and its management in primary care setting
Mahmoud Ibrahim, Ebtesam Ba-Essa, Jessica A. Alvarez, et al.
Journal of Diabetes and its Complications (2025) Vol. 39, Iss. 7, pp. 109045-109045
Closed Access
The influence of the glucagon‐like peptide‐1 receptor agonist, liraglutide, on dietary patterns and nutrient intakes in patients with obesity and prediabetes: A secondary analysis of a randomized controlled trial
Kelli M. Richardson, Susan M. Schembre, Michelle R Jospe, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Symptomatic Adverse Events and Quality of Life Related to Incretin-Based Medicines for Obesity: A Systematic Review Involving >400,000 Subjects
Robert F. Kushner, Odd Erik Johansen, Krysmarú Araujo Torres, et al.
Obesities (2025) Vol. 5, Iss. 2, pp. 29-29
Open Access
CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes
Oliver Schnell, Jaime P. Almandoz, Lisa Anderson, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Optimizing Nutrition, Diet, and Lifestyle Communication in GLP-1 Medication Therapy for Weight Management: A Qualitative Research Study with Registered Dietitians
David Despain, Brenda Louise Hoffman
Obesity Pillars (2024) Vol. 12, pp. 100143-100143
Open Access | Times Cited: 3
Dietary Patterns and Nutritional Status in Bariatric Surgery Candidates—A Cross-Sectional Study
Kamila Sobaś, Edyta Suliga, Piotr Bryk, et al.
Nutrients (2025) Vol. 17, Iss. 4, pp. 716-716
Open Access
One Size Does Not Fit All: Special Considerations for Behavioral Health Providers Treating Patients Using GLP-1RA Medications for Obesity
Noreen A. Reilly-Harrington, Susan Himes, Jennifer Lauretti-Robbins, et al.
Cognitive and Behavioral Practice (2025)
Closed Access
Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study
Brittany Johnson, Mary Milstead, Owen Thomas, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Knowing Well, Being Well: well-being born of understanding: Access to GLP-1s: Where Do Employers Fit in?
Mary T. Imboden
American Journal of Health Promotion (2025) Vol. 39, Iss. 5, pp. 828-843
Closed Access
The Critical Role of Lifestyle With the Use of Contemporary Obesity Management Medications
Renee J. Rogers, Michael P. Hosking, Karlijn Burridge, et al.
American Journal of Health Promotion (2025) Vol. 39, Iss. 5, pp. 836-840
Closed Access
“From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
Adrian Brown, Duane Mellor, Janine Makaronidis, et al.
Nutrition Bulletin (2024) Vol. 49, Iss. 3, pp. 257-263
Open Access | Times Cited: 2
Incretin-Based Therapies and Lifestyle Interventions: The Evolving Role of Registered Dietitian Nutritionists in Obesity Care
Linda Gigliotti, Hope Warshaw, Alison B. Evert, et al.
Journal of the Academy of Nutrition and Dietetics (2024)
Closed Access | Times Cited: 2
Nutrition’s Role in Quality Healthcare in the United States: Opportunities and Education for Pharmacists to Take a Bite of the Apple and Strengthen Their Skills
Jeff Cai, Andie Lee Gonzalez, Mary Beth Arensberg
Pharmacy (2024) Vol. 12, Iss. 4, pp. 103-103
Open Access | Times Cited: 1
Severe obesity and current treatment in the UK: a call for radical reshaping of services
James Byrne
Bulletin of The Royal College of Surgeons of England (2024) Vol. 106, Iss. 6, pp. 330-333
Open Access | Times Cited: 1
Anti‐Obesity Medication in the Management of Children and Adolescents With Obesity: Recent Developments and Research Gaps
Gabriel Torbahn, Julia Lischka, Tamara Brown, et al.
Clinical Endocrinology (2024)
Open Access | Times Cited: 1
Adipositas und Diabetes
Jens Aberle, Anne Lautenbach, Svenja Meyhöfer, et al.
Diabetologie und Stoffwechsel (2024) Vol. 19, Iss. S 02, pp. S270-S278
Closed Access | Times Cited: 1
Response to the Letter to the Editor by Bett et al.
Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury, et al.
Obesity (2024)
Open Access
Response to the Letter to the Editor by Athinarayanan
Jaime P. Almandoz, Thomas A. Wadden, Colleen Tewksbury, et al.
Obesity (2024)
Open Access
Response to “Nutritional considerations with antiobesity medications”
Shaminie J. Athinarayanan
Obesity (2024)
Closed Access
Page 1

Scroll to top